Skip to content

Experimental study on the control of axillary artery bleeding by a new junction tourniquet

Experimental study on the control of axillary artery bleeding by a new junction tourniquet

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040362
Enrollment
Unknown
Registered
2020-11-28
Start date
2020-11-27
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic hemorrhage of the axillary artery

Interventions

Case series:Hemostatic device

Sponsors

Army Specialty Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Aged at least 18 years old; 2. Have complete cognitive ability and judgment.

Exclusion criteria

Exclusion criteria: A history of shoulder and chest surgery or any disease or other surgery in the last 6 months.

Design outcomes

Primary

MeasureTime frame
none;

Contacts

Public ContactLian-Yang Zhang

Army Specialty Medical Center

dpzhangly@163.com+86 13508308400

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026